论文信息 - Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. - 字舞流文

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.

T. Cate | W. Keitel | K. Edwards | E. Walter | C. Dekker | J. Treanor | P. Winokur | H. Talbot | R. Brady | D. Ho | M. Skeljo | G. Hartel | Irene L Graham | J. Bennet | J. Campbell | N. Formica | J. Campbell | K. Edwards

[1] F. Newman,et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. , 2007, Vaccine.

[2] K. Pfeffer,et al. Severe serum sickness following pneumococcal vaccination in an AIDS patient , 2006, International journal of STD & AIDS.

[3] W. Keitel,et al. Rapid Licensure of a New, Inactivated Influenza Vaccine in the United States , 2005, Human vaccines.

[4] Tiered use of inactivated influenza vaccine in the event of a vaccine shortage. , 2005, MMWR. Morbidity and mortality weekly report.

[5] F. Newman,et al. Serum antibody responses after intradermal vaccination against influenza. , 2004, The New England journal of medicine.

[6] C. Bridges,et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7] G. Poland,et al. Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults. , 2003, Vaccine.

[8] Lead Visual Information Specialist , 2001 .

[9] N. Cox. Prevention and control of influenza. , 1999, Lancet.